Authors

• Doriana Cellura
• Anna Chilcott
• Maria G. Belvisi (ORCID: https://orcid.org/0000-0003-1652-4370)
• Clint Zvavamwe
• Karl J. Staples (ORCID: https://orcid.org/0000-0003-3844-6457)
• C. Mirella Spalluto (ORCID: https://orcid.org/0000-0001-7273-0844)
• Aiman Alzetani (ORCID: https://orcid.org/0000-0002-3373-6714)
• Francis Sundram
• Kristoffer Ostridge (ORCID: https://orcid.org/0000-0001-8910-3900)
• Michael J. Bennett (ORCID: https://orcid.org/0000-0002-2930-4900)
• Benjamin Welham (ORCID: https://orcid.org/0000-0001-9683-252X)
• Alex Kong
• Darren Henley
• Aishath Fazleen (ORCID: https://orcid.org/0000-0002-1286-9374)
• Peter M. Lackie (ORCID: https://orcid.org/0000-0001-7138-3764)
• Emily Shaw
• Paul H. Lee (ORCID: https://orcid.org/0000-0002-5729-6450)
• Sandra Johns
• Adam Platt (ORCID: https://orcid.org/0009-0008-0109-7699)
• Christopher McCrae (ORCID: https://orcid.org/0000-0001-7184-9069)
• Matthew Guy (ORCID: https://orcid.org/0000-0002-6818-2010)
• Tom Wilkinson (ORCID: https://orcid.org/0000-0003-1771-3851)
• Matthew Lawson (ORCID: https://orcid.org/0000-0003-0115-1698)
• Sofia Michopoulou (ORCID: https://orcid.org/0000-0003-1974-8388)
• Stephen P. Harden (ORCID: https://orcid.org/0000-0002-9995-6058)

Institutions

• AstraZeneca (United Kingdom) (GB)
• Southampton General Hospital (GB)
• University Hospital Southampton NHS Foundation Trust (GB)
• NIHR Southampton Respiratory Biomedical Research Unit (GB)
• AstraZeneca (Finland) (FI)
• AstraZeneca (Sweden) (SE)
• AstraZeneca (United States) (US)
• University of Southampton (GB)
• Imperial College London (GB)

Publication Details

Journal

ERJ Open Research

Published

2025-07-24

DOI

https://doi.org/10.1183/23120541.01246-2024

Primary Topic

Chronic Obstructive Pulmonary Disease (COPD) Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• AstraZeneca
• Queen Mary University of London
• University Hospital Southampton NHS Foundation Trust
• University of Southampton